Skip to content

Transmuscular Quadratus Lumborum Block for Postoperative Pain After Laparoscopic Adrenalectomy

Transmuscular Quadratus Lumborum Block for Postoperative Pain After Laparoscopic Adrenalectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03942237
Enrollment
72
Registered
2019-05-08
Start date
2019-05-10
Completion date
2019-09-02
Last updated
2020-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparoscopic Adrenalectomy, Nerve Block, Pain Management

Keywords

transmuscular quadratus lumborum block, adrenalectomy

Brief summary

This prospective, randomized control study aims to compare the analgesic effect, satisfaction with anesthesia and analgesia between single-injection QLB (quadratus lumborum block)+general anesthesia (GA) and general anesthesia (GA) alone in patients undergoing laparoscopic adrenalectomy.

Interventions

Inject 0.4ml/kg 0.5% ropivacaine between quadratus lumborum and psoas major muscle Device: The curved (C1-5) probe of Ultrasound Scanner Philips CX50 is used for scan Drug: single dose ropivacaine 0.4ml/kg 0.5% ropivacaine is given immediately after the correct position of needle tip is verified.

PROCEDUREPlacebo Control

Inject 0.4ml/kg saline between quadratus lumborum and psoas major muscle Device: The curved (C1-5) probe of Ultrasound Scanner Philips CX50 is used for scan Drug: single dose 0.4ml/kg 0.9% NS is given immediately after the correct position of the needle tip is verified

Sponsors

Peking Union Medical College Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-70 yrs * American Society of Anesthesiologists physical statusⅠ-Ⅲ * Undergo laparoscopic adrenalectomy * Informed consent

Exclusion criteria

* a known allergy to the medications being used for anesthesia * coagulopathy or on anticoagulants * chronic opioid therapy or history of substance abuse * participating in another RCT * inability to properly describe postoperative pain to investigators (e.g., language barrier, neuropsychiatric disorder).

Design outcomes

Primary

MeasureTime frameDescription
the NRS pain scores on activity 12-hours after surgery12-hours after surgeryThe NRS (a number scale from 0 to 10) is a commonly used pain intensity rating tool

Secondary

MeasureTime frameDescription
incidence of postoperative nausea and vomiting (PONV)within 24 postoperative hours
ambulation timewithin 5 days after surgery
time of recovery of bowel movementwithin 5 days after surgerydefined as the time to first flatus
the pain scores at rest determined by the numeric rating scale (NRS, 0-10)At 2,4, 8, 12, 24 ,48,72 hours after the surgeryThe NRS (a number scale from 0 to 10) is a commonly used pain intensity rating tool
patient's satisfaction of anesthesia and analgesia48 hours after surgeryuse the Chinese version of Bauer questionnaire to assess the patient satisfaction of anesthesia
the NRS pain scores on activity after surgeryAt 2,4, 8, 24 ,48,72 hours after the surgeryThe NRS (a number scale from 0 to 10) is a commonly used pain intensity rating tool
postoperative length of hospital stayup to 2 weeks after surgery

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026